RXRX
Recursion Pharmaceuticals, Inc. · Healthcare
3.19
1.27%(+0.04)
Close3.24
1.57%(+0.05)
After HoursLast Updated: — ET
52W L: $2.8052W H: $7.18
$3.23
CHG-0.12 (-3.56%)
H$3.57
L$2.80
VOL245M
RXRX (1h)
Recursion Pharmaceuticals, Inc. · Healthcare
Salt Lake City, April 07, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation in the following upcoming investor conferences: 25th Annual Needham Virtual Healthcare Conference - Monday, April 13, 2026 Bank of America Health Care Conference 2026 - Tuesday, May 12, 2026 Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com . About Recursion Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives.
Recursion Pharmaceuticals (RXRX) reached $3.11 at the closing of the latest trading day, reflecting a +1.63% change compared to its last close.
One of these is not like the other.
Citeline, a leader in clinical solutions for the life sciences, announced an expanded strategic partnership with Recursion, a leading tech-bio company.
AI-powered drug discovery and development is now a possibility. Artificial intelligence is also able to help caregivers navigate a complex collection of ever-changing treatment options.
The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $2.94, representing a -6.67% change from its previous close.
Dar Zavain
director
4,902 SH @ $0.00
2026-04-01
Li Dean Y
director
3,268 SH @ $0.00
2026-04-01
Gibson Christopher
director
40,000 SH @ $0.00
2026-03-23
Gibson Christopher
director
40,000 SH @ $0.00
2026-03-23
Gibson Christopher
director
40,000 SH @ $3.25
2026-03-23
Taylor Ben R
officer: Chief Financial Officer
7,075 SH @ $3.42
2026-03-16
Taylor Ben R
officer: Chief Financial Officer
7,956 SH @ $3.39
2026-03-17
Gibson Christopher
director
20,000 SH @ $0.00
2026-03-09